Qiagen Nv Stock Revenue
| QGEN Stock | USD 43.25 0.47 1.10% |
Qiagen NV fundamentals help investors to digest information that contributes to Qiagen NV's financial success or failures. It also enables traders to predict the movement of Qiagen Stock. The fundamental analysis module provides a way to measure Qiagen NV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Qiagen NV stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 2 B | 1 B |
Qiagen | Revenue |
Qiagen NV Company Revenue Analysis
Qiagen NV's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Qiagen NV Revenue | 1.97 B |
Most of Qiagen NV's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Qiagen NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Qiagen
Projected quarterly revenue analysis of Qiagen NV provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Qiagen NV match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Qiagen NV's stock price.
Qiagen Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Qiagen NV is extremely important. It helps to project a fair market value of Qiagen Stock properly, considering its historical fundamentals such as Revenue. Since Qiagen NV's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Qiagen NV's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Qiagen NV's interrelated accounts and indicators.
| 0.79 | 0.93 | 0.21 | 0.92 | 0.53 | ||
| 0.79 | 0.84 | 0.28 | 0.87 | 0.66 | ||
| 0.93 | 0.84 | 0.31 | 0.99 | 0.55 | ||
| 0.21 | 0.28 | 0.31 | 0.36 | 0.41 | ||
| 0.92 | 0.87 | 0.99 | 0.36 | 0.63 | ||
| 0.53 | 0.66 | 0.55 | 0.41 | 0.63 |
Click cells to compare fundamentals
Qiagen Revenue Historical Pattern
Today, most investors in Qiagen NV Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Qiagen NV's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Qiagen NV revenue as a starting point in their analysis.
Qiagen NV Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Qiagen Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Qiagen NV reported 1.97 B of revenue. This is 74.23% lower than that of the Life Sciences Tools & Services sector and about the same as Health Care (which currently averages 1.98 B) industry. The revenue for all United States stocks is 79.17% higher than that of the company.
Qiagen Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Qiagen NV's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Qiagen NV could also be used in its relative valuation, which is a method of valuing Qiagen NV by comparing valuation metrics of similar companies.Qiagen NV is currently under evaluation in revenue category among its peers.
Qiagen NV Current Valuation Drivers
We derive many important indicators used in calculating different scores of Qiagen NV from analyzing Qiagen NV's financial statements. These drivers represent accounts that assess Qiagen NV's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Qiagen NV's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 7.4B | 11.7B | 12.3B | 11.0B | 9.9B | 10.4B | |
| Enterprise Value | 8.5B | 13.1B | 13.4B | 12.1B | 10.9B | 11.4B |
Qiagen NV ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Qiagen NV's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Qiagen NV's managers, analysts, and investors.Environmental | Governance | Social |
Qiagen NV Institutional Holders
Institutional Holdings refers to the ownership stake in Qiagen NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Qiagen NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Qiagen NV's value.| Shares | Dekabank Deutsche Girozentrale | 2024-06-30 | 3.2 M | Millennium Management Llc | 2024-06-30 | 3 M | Victory Capital Management Inc. | 2024-09-30 | 2.6 M | Bnp Paribas Arbitrage, Sa | 2024-06-30 | 2.5 M | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 2.4 M | State Street Corp | 2024-06-30 | 2.3 M | Legal & General Group Plc | 2024-06-30 | 2.2 M | Citadel Advisors Llc | 2024-09-30 | 2.1 M | Deutsche Bank Ag | 2024-06-30 | 2.1 M | Massachusetts Financial Services Company | 2024-09-30 | 23.1 M | Wellington Management Company Llp | 2024-06-30 | 12 M |
Qiagen Fundamentals
| Return On Equity | 0.0257 | ||||
| Return On Asset | 0.0484 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 10.05 B | ||||
| Shares Outstanding | 222.26 M | ||||
| Shares Owned By Insiders | 2.24 % | ||||
| Shares Owned By Institutions | 87.72 % | ||||
| Number Of Shares Shorted | 3.57 M | ||||
| Price To Earning | 24.32 X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 4.89 X | ||||
| Revenue | 1.97 B | ||||
| Gross Profit | 1.44 B | ||||
| EBITDA | 650.58 M | ||||
| Net Income | 341.3 M | ||||
| Cash And Equivalents | 1.89 B | ||||
| Cash Per Share | 8.31 X | ||||
| Total Debt | 1.61 B | ||||
| Debt To Equity | 0.69 % | ||||
| Current Ratio | 1.84 X | ||||
| Book Value Per Share | 15.88 X | ||||
| Cash Flow From Operations | 459.45 M | ||||
| Short Ratio | 3.62 X | ||||
| Earnings Per Share | 0.44 X | ||||
| Price To Earnings To Growth | 1.00 X | ||||
| Target Price | 50.59 | ||||
| Number Of Employees | 5.8 K | ||||
| Beta | 0.4 | ||||
| Market Capitalization | 9.61 B | ||||
| Total Asset | 6.12 B | ||||
| Retained Earnings | 2.46 B | ||||
| Working Capital | 1.07 B | ||||
| Current Asset | 193.04 M | ||||
| Current Liabilities | 81.49 M | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 6.12 B |
About Qiagen NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Qiagen NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Qiagen NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Qiagen NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Qiagen NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.Moving together with Qiagen Stock
Moving against Qiagen Stock
| 0.76 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.72 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.56 | EXEL | Exelixis | PairCorr |
| 0.5 | FLGC | Flora Growth Corp | PairCorr |
| 0.46 | KTTAW | Pasithea Therapeutics | PairCorr |
The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.
The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Qiagen NV Piotroski F Score and Qiagen NV Altman Z Score analysis. To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.255 | Earnings Share 0.44 | Revenue Per Share 8.841 | Quarterly Revenue Growth 0.055 | Return On Assets 0.0484 |
The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.